Makoto Inoue

Profile
Tenure
Jan 2025 – Present
Years in office
1.8 years
Name in Japanese
井上眞
Title at appointment
Representative Director, President and CEO
Performance in office
Otsuka Holdings
Performance in office
FY2024FY2025Change
Revenue¥2.3trillion¥2.5trillion+6%
Net margin14.7%14.7%±0.0pt
HiguchiInoue
Revenue¥2.5 trillionNet margin14.7%2020/122025/122030/12
Revenue¥2.5 trillionNet margin14.7%2020/122025/122030/12
Tenure

Tenure

Background

He joined Otsuka Pharmaceutical in April 1983. He became an Executive Officer in June 2008, his 26th year with the company, then Managing Executive Officer in June 2009, Director and Senior Managing Executive Officer in March 2015, and Director and Executive Vice President in March 2019. In March 2020 he became Representative Director and President of Otsuka Pharmaceutical and, that same month, a Director of Otsuka Holdings. In January 2024 he became Representative Director and COO of the holding company.

Education: Nagasaki Prefectural University of International Economics, Faculty of Economics (now University of Nagasaki) (1983)

Selection

In January 2025 he became Representative Director, President and CEO, succeeding Tatsuo Higuchi. Higuchi, who had led the company for about 25 years since 2000, stepped back to Director and Senior Advisor. Inoue had become Representative Director and COO of the holding company in January 2024, rising from COO to President in one year. In the fiscal year before he took office, ended December 2024, consolidated revenue was ¥2,329.8 billion and operating income ¥323.6 billion. Among major shareholders, a trust account of the Otsuka founding family's shareholding association ranked second with 9.91%.

Initiatives

In his first fiscal year, ended December 2025, consolidated revenue was ¥2,468.8 billion and operating income ¥479.4 billion, both above the previous year's ¥2,329.8 billion and ¥323.6 billion. Net income also rose from ¥343.1 billion to ¥363.1 billion. He has been in office for about a year, and no decision traceable as a policy initiative has yet emerged.

Career

Career

Otsuka Pharmaceutical

Date Position
Apr 1983 Joined
Jun 2008 Executive Officer
Jun 2009 Managing Executive Officer
Mar 2015 Director and Senior Managing Executive Officer
Mar 2019 Executive Vice President
Mar 2020 Representative Director, President

Otsuka Holdings

Date Position
Mar 2020 Director
Jan 2024 Representative Director, COO
Jan 2025 Representative Director, President and CEO
References 1

References (Japanese primary sources)

  • 大塚ホールディングス 有価証券報告書【役員の状況】